Laura Riolobos

1.2k citations
9 papers · 892 · 1 hit paper · h-index 8

Impact in

  • Oncology top 10%
    • CAR-T cell therapy research
  • Genetics top 10%
    • Virus-based gene therapy research

Papers in

    • Nuclear Structure and Function 3
    • CRISPR and Genetic Engineering 2
    • Epigenetics and DNA Methylation 1
    • Pluripotent Stem Cells Research 1
    • Cell death mechanisms and regulation 1
    • Parvovirus B19 Infection Studies 4

Laura Riolobos

9 papers receiving 870 citations

Laura Riolobos's Hit Papers

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells 2017 · 464 citations
4640+3+6Years since publication100200300400

Peers

Laura Riolobos
Comparison fields: 5 of 65
  • Oncology 290
  • Genetics 217
  • Immunology 149
  • Molecular Biology 492
  • Animal Science and Zoology 62
Replace Lauren E. Mays with:
Lauren E. Mays United States
Alessio Cantore Italy
Suryanarayan Somanathan United States
Tanja Hakkarainen Finland
Justin C. Roth United States
Ángel Cid-Arregui Germany
Maria Teresa Sáenz-Robles United States
Katsunori Shinozaki United States
A Jani Canada
Zsolt Fábián Hungary
Laura Riolobos relative to Lauren E. Mays United States Lauren E. Mays's profile →
Citations per field
00.5×2.7×
Lauren E. Mays · 1×
Citations per year

Countries citing papers authored by Laura Riolobos

Since Specialization
Citations

This map shows the geographic impact of Laura Riolobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Riolobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Riolobos more than expected).

Fields of papers citing papers by Laura Riolobos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Riolobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Riolobos. The network helps show where Laura Riolobos may publish in the future.

Co-authors

The 25 scholars most cited alongside Laura Riolobos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laura Riolobos Line = papers co-authored together Laura Riolobos links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Hit paper breakdown →
2017464
2 2013201
3 200481
4 200656
5 200932
6 202125
7 201518
8 201910
9 20185

About Laura Riolobos

Laura Riolobos is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 892 indexed citations. Recurring topics across this work include Parvovirus B19 Infection Studies (4 papers), Virus-based gene therapy research (4 papers), Nuclear Structure and Function (3 papers), CRISPR and Genetic Engineering (2 papers), Epigenetics and DNA Methylation (1 paper), Pluripotent Stem Cells Research (1 paper), Polyomavirus and related diseases (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Oncology (290 citations), Genetics (217 citations), Immunology (149 citations), Molecular Biology (492 citations) and Animal Science and Zoology (62 citations). Laura Riolobos has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Cameron J. Turtle, Germán G. Gornalusse, David W. Russell, Roli K. Hirata, José M. Almendral, Gabriel Manske, Laïla‐Aïcha Hanafi, Vanda S. Lopes, Donna Prunkard and Sarah E. Funk. Their work appears in journals such as Virology, Journal for ImmunoTherapy of Cancer, Journal of Virology, PLoS Pathogens and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact